Ekso Bionics Announces Partnership with U.S. Physiatry to Support Physician Education of EksoNR
09. März 2021 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Teams Up with Performance Contracting, Inc. for Innovative Testing Approach of EVO™ Technology
03. März 2021 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Present at the H.C. Wainwright Global Life Sciences Conference
02. März 2021 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that...
Ekso Bionics Reports Fourth Quarter and Year End 2020 Results
25. Februar 2021 16:05 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics® to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
18. Februar 2021 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it...
Ekso Bionics Announces Closing of $40 Million Bought Deal Offering
11. Februar 2021 16:35 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Increases Previously Announced Bought Deal Offering of Common Stock to $40 Million
08. Februar 2021 23:30 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Announces $10 Million Bought Deal Offering Of Common Stock
08. Februar 2021 17:11 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2020 Financial Results
13. Januar 2021 16:05 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced...
Ekso Bionics to Present at the H.C. Wainwright BioConnect 2021 Conference
05. Januar 2021 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack...